Zobrazeno 1 - 10
of 6 839
pro vyhledávání: '"advanced breast cancer"'
Autor:
Nathan A. Clarke, Brendon Wong, Rachael Lawrance, Anders Ingelgård, Ingolf Griebsch, David Cella, Andrew Trigg
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background Breast cancer is one of the most common cancers in women. Patient-reported outcome measures are used to evaluate patients’ health-related quality of life in clinical breast cancer studies. This study evaluated the structure, val
Externí odkaz:
https://doaj.org/article/c8c133fb5818480080b343a7b39677fb
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 837-842 (2024)
Background: Due to its indolent biology and high estrogen receptor positivity of mucinous breast cancer, vast majority of locally advanced mucinous breast cancer (LABC) are treated with first-line endocrine therapy. Case Presentation: A 50-year-old w
Externí odkaz:
https://doaj.org/article/6070d88ab98748d6aba39af661c93a57
Autor:
Zhe-Yu Hu, Binliang Liu, Ning Xie, Xiaohong Yang, Liping Liu, Huawu Xiao, Jing Li, Hui Wu, Jianxiang Gao, Jun Lu, Xuming Hu, Min Cao, Zhengrong Shui, Can Tian, Quchang Ouyang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Aims This investigation aims to elucidate the treatment status of advanced HR+/HER2- breast cancer patients in Hunan Province of Central Southern China from November 2021 to December 2022. Methods Data from 301 patients with advanced HR+/HER
Externí odkaz:
https://doaj.org/article/e9c30214395a45e9b2c6da56ab5e2a2c
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 182-189 (2024)
The classification of breast cancer (BC) by immunohistochemical phenotypes is widely used in routine clinical practice. However, the genetic profile of the tumor does not always correspond to the pathomorphological one, which can significantly affect
Externí odkaz:
https://doaj.org/article/9bd059acb1804b48b14f790646bef706
Autor:
Cheng-Yu Zeng, Yan-Yu Qiu, Jia-Yi Li, Jian-Hao Huang, Xue-Song Bai, Xian-Lin Han, Xiao-Dong He
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background The purpose of this study was to compare safety and efficacy outcomes between immediate breast reconstruction (IBR) and mastectomy alone in locally advanced breast cancer patients. Methods We conducted a comprehensive literature s
Externí odkaz:
https://doaj.org/article/709e04aec2054ed68109a2b1e469c4f5
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-34 (2024)
Abstract Locally advanced breast cancer (LABC) is a heterogeneous group of breast cancer that accounts for 10–30% of breast cancer cases. Despite the ongoing development of current treatment methods, LABC remains a severe and complex public health
Externí odkaz:
https://doaj.org/article/9807b100f67a42e7b2a647c5080c14df
Autor:
Letizia Cuniolo, Marco Gipponi, Federica Murelli, Francesca Depaoli, Chiara Cornacchia, Simonetta Franchelli, Marianna Pesce, Elena Ronda, Stefano Picardi, Raquel Diaz, Francesca Poggio, Daniele Friedman, Franco De Cian, Piero Fregatti
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2856-2866 (2024)
Locally advanced breast cancer (LABC) is a complex disease that requires a multidisciplinary approach. Neoadjuvant chemotherapy (NAC) is usually performed in order to achieve loco-regional radical resection; although its importance in the multidiscip
Externí odkaz:
https://doaj.org/article/73704bc0fb9649ce83be32abb56a0f0d
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 163-179 (2024)
Shuling Wang,1,2,* Yuqin Chen,1– 3,* Weidong Li,2,4,* Chunfang Hao,1,2 Li Zhang,1,2 Weipeng Zhao,1,2 Yehui Shi,1,2 Zhongsheng Tong1,2 1Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Cli
Externí odkaz:
https://doaj.org/article/d6b2dda8accd44d78127c76fe3eae6ef
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAdvanced breast cancer (ABC) is a heterogeneous disease with varied prognoses, that is affected by many clinicopathological features. This study aimed to investigate the clinicopathological characteristics, first-line treatment (FLx), and p
Externí odkaz:
https://doaj.org/article/63d23351c40c468f86fd292e18e1850e
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
Locally advanced breast cancer (LABC) remains a significant clinical challenge, particularly in developing countries. While neoadjuvant systemic therapy (NST) has improved the pathological complete response (pCR) rates, particularly in HER2-positive
Externí odkaz:
https://doaj.org/article/0c92d8455b214a02971b172b7c5be410